Dementia Risk Score Developed in U.K. Biobank, Whitehall Cohorts
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 25, 2023 -- A novel risk score can identify individuals at risk for dementia in the United Kingdom, according to a study published online Aug. 24 in BMJ Mental Health.
Malis Anatürk, D.Phil., from University College London, and colleagues developed and validated a novel dementia risk score for a midlife U.K. population using the U.K. Biobank and U.K. Whitehall II study. The U.K. Biobank cohort was divided into a training cohort and test sample (176,611 and 44,151 participants, respectively), and the Whitehall II cohort was used for external validation (2,934 participants). The strongest predictors of incident dementia from 28 candidates were selected, and a risk score was developed using competing risk regression.
The risk score (U.K. Biobank Dementia Risk Score [UKBDRS]) includes age, education, parental history of dementia, material deprivation, a history of diabetes, stroke, depression, hypertension, high cholesterol, household occupancy, and sex. The researchers found that the score had strong discrimination accuracy in the U.K. Biobank test sample and in the Whitehall II cohort (area under the curve, 0.8 and 0.77, respectively). The UKBDRS outperformed other widely used dementia risk scores developed in cohorts in Australia, Finland, and the United Kingdom: the Australian National University Alzheimer's Disease Risk Index, the Cardiovascular Risk Factors, Ageing, and Dementia score, and the Dementia Risk Score.
"While the consistent performance of UKBDRS across these two independent groups boosts our confidence in its viability, we need to evaluate it across more diverse groups of people both within and beyond the UK," coauthor Raihaan Patel, Ph.D., from the University of Oxford in the United Kingdom, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
FRIDAY, May 31, 2024 -- Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent at...
Preeclampsia Linked to Increased Risk for Young-Onset Dementia
FRIDAY, May 31, 2024 -- Individuals with preeclampsia have an increased risk for young-onset dementia, according to a research letter published online May 30 in JAMA Network...
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.